Drug Profile
FKW 00GA
Alternative Names: FKW00GA; TGW 00AA; TGW00AA HCl; TGWOOAA; TGWOOAA HClLatest Information Update: 15 Jun 2021
Price :
$50
*
At a glance
- Originator Unknown
- Developer Fabre-Kramer Pharmaceuticals
- Class Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Generalised anxiety disorder; Sexual function disorders; Social phobia
Most Recent Events
- 15 Jun 2021 Phase II development is ongoing for Sexual function disorders, Social phobia and Generalised anxiety disorder in USA (PO) (Fabre-Kramer Pharmaceuticals pipeline, June 2021)